Skip to Content

RAPAMUNE 0.5 mg (Rapamune 0.5 mg)

Generic Name: sirolimus

Pill imprint RAPAMUNE 0.5 mg has been identified as Rapamune 0.5 mg.

Rapamune is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rapamune 0.5 mg RAPAMUNE 0.5 mg
Rapamune 0.5 mg RAPAMUNE 0.5 mg
Discount Card Promo
Rapamune
Generic Name:
sirolimus
Imprint:
RAPAMUNE 0.5 mg
Strength:
0.5 mg
Color:
Tan
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Wyeth Laboratories
National Drug Code (NDC):
00008-1040
Inactive Ingredients:
sucrose
polyethylene glycol 8000
calcium sulfate
microcrystalline cellulose
magnesium silicate
titanium dioxide
magnesium stearate
povidone k29/32
lactose monohydrate
poloxamer 188
carnauba wax
ferric oxide yellow
alpha tocopherol acetate
glyceryl oleate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
59762-1001 Greenstone LLC

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide